F T Ageev - JoVE Visualize

Showing results (41-50 of 81) with videos related to

Pageof 9

Sort By:

Kardiologiia|July 26, 2019

[Mechanisms of exercise intolerance in patients with heart failure and preserved ejection fraction. Part I: The role of impairments in the left heart chambers]A G Ovchinnikov, A V Potekhina, N M Ibragimova, et al.

Kardiologiia|February 14, 2015

[The ability to use meldonium as adaptogen in winter in patients with cardiovascular disease]M D Smirnova, O N Svirida, F T Ageev, et al.

Kardiologiia|October 20, 2005

[Confirmation of safety and therapeutic effect of betaxolol in the treatment of mild and moderate hypertension in general medical practice]Iu B Belousov, N A Egorova, B A Sidorenko, et al.

Kardiologiia|December 7, 2002

[Multicenter Study of Efficacy and Safety of a Preparation of Lovastatin in Patients With Ischemic Heart Disease and Mild or Moderate Hypercholesterolemia]Iu. P. Nikitin, G. I. Simonova, V. Iu. Mareev, et al.

Kardiologiia|February 12, 2010

[ATR1 gene polymorphism in patients with hypertrophic cardiomyopathy and hypertensive heart]M D Smirnova, T V Fofanova, Z B Khasanova, et al.

Kardiologiia|February 1, 1992

[Use of functional classes to assess the status of patients with severe heart failure]F T Ageev, V V Gerasimova, V Iu Mareev, et al.

Kardiologiia|May 1, 1992

[Anaerobic threshold in patients with chronic circulatory insufficiency]V G Floria, N E Aĭdargalieva, V E Sinitsyn, et al.

Acta Naturae|August 4, 2020

The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection FractionA G Ovchinnikov, T I Arefieva, A V Potekhina, et al.

Voprosy Onkologii|January 30, 2019

[Cardiotoxicity of trastuzumab: mechanisms of development, diagnosis, treatment]A G Ovchinnikov, A V Skorobogatova, T Yu Seiniglazova, et al.

Kardiologiia|August 2, 2017

[The First Experience of Using Very Long Stents Covered With Sirolimus (4060 mm) in the Treatment of Patients With Extensive and Diffuse Lesions of the Coronary Arteries]Yu G Matchin, R V Atanesyan, E N Kononets, et al.

Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:

Pageof 9

Kardiologiia|July 26, 2019

[Mechanisms of exercise intolerance in patients with heart failure and preserved ejection fraction. Part I: The role of impairments in the left heart chambers]A G Ovchinnikov, A V Potekhina, N M Ibragimova, et al.

Kardiologiia|February 14, 2015

[The ability to use meldonium as adaptogen in winter in patients with cardiovascular disease]M D Smirnova, O N Svirida, F T Ageev, et al.

Kardiologiia|October 20, 2005

[Confirmation of safety and therapeutic effect of betaxolol in the treatment of mild and moderate hypertension in general medical practice]Iu B Belousov, N A Egorova, B A Sidorenko, et al.

Kardiologiia|December 7, 2002

[Multicenter Study of Efficacy and Safety of a Preparation of Lovastatin in Patients With Ischemic Heart Disease and Mild or Moderate Hypercholesterolemia]Iu. P. Nikitin, G. I. Simonova, V. Iu. Mareev, et al.

Kardiologiia|February 12, 2010

[ATR1 gene polymorphism in patients with hypertrophic cardiomyopathy and hypertensive heart]M D Smirnova, T V Fofanova, Z B Khasanova, et al.

Kardiologiia|February 1, 1992

[Use of functional classes to assess the status of patients with severe heart failure]F T Ageev, V V Gerasimova, V Iu Mareev, et al.

Kardiologiia|May 1, 1992

[Anaerobic threshold in patients with chronic circulatory insufficiency]V G Floria, N E Aĭdargalieva, V E Sinitsyn, et al.

Acta Naturae|August 4, 2020

The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection FractionA G Ovchinnikov, T I Arefieva, A V Potekhina, et al.

Voprosy Onkologii|January 30, 2019

[Cardiotoxicity of trastuzumab: mechanisms of development, diagnosis, treatment]A G Ovchinnikov, A V Skorobogatova, T Yu Seiniglazova, et al.

Kardiologiia|August 2, 2017

[The First Experience of Using Very Long Stents Covered With Sirolimus (4060 mm) in the Treatment of Patients With Extensive and Diffuse Lesions of the Coronary Arteries]Yu G Matchin, R V Atanesyan, E N Kononets, et al.

Pageof 9